March 24th, 2026
Announcement regarding the Marketing Authorization Application for Borofalan (10B) used in BNCT for Angiosarcoma
We are pleased to announce that today we submitted the application to the Min……
2026年3月
March 17th, 2026
Announcement regarding the Marketing Authorization Application for Borofalan (10B), used in BNCT for Recurrent Meningioma
We are pleased to announce that we submitted today the application to the Minis……
